| Unique ID issued by UMIN | UMIN000055920 |
|---|---|
| Receipt number | R000063901 |
| Scientific Title | A 12-month single-center, single-arm comparative study on the efficacy and safety of esophageal rehabilitation for acid suppressive medication-resistant gastroesophageal reflux disease |
| Date of disclosure of the study information | 2024/10/23 |
| Last modified on | 2024/10/23 13:26:38 |
A 12-month single-center, single-arm comparative study on the efficacy and safety of esophageal rehabilitation for acid suppressive medication-resistant gastroesophageal reflux disease
A 12-month study of esophageal rehabilitation for refractory gastroesophageal reflux disease
A 12-month single-center, single-arm comparative study on the efficacy and safety of esophageal rehabilitation for acid suppressive medication-resistant gastroesophageal reflux disease
A 12-month single-center, single-arm comparative study of esophageal rehabilitation for acid suppressive medication-resistant gastroesophageal reflux disease
| Japan |
gastroesophageal reflux disease
| Medicine in general | Gastroenterology | Rehabilitation medicine |
Others
NO
Alleviation of the symptom of gastro-esophageal reflux disease (GERD)
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
The numerical value change of FSSG (Frequency Scale for the Symptoms of GERD) after 12 months' esophageal exercise therapy.
Changes in FSSG 2-4 weeks, 3 months, and 2 years after starting exercise therapy. Changes in acid suppressive medication intake and endoscopic mucosal lesions 2-4 weeks, 3 months, 1 year, and 2 years after starting exercise therapy. For those who gain consent, pH monitoring (24-hour esophageal pH monitoring or 24-hour esophageal impedance/pH monitoring) and manometry findings.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Treatment
| Maneuver |
Swallowing training will be conducted 10 times at 7 to 10 seconds intervals in a supine position with their lower back raised. The program is performed twice a day for 12 months.
| 20 | years-old | <= |
| 100 | years-old | >= |
Male and Female
Patients with GERD, whose symptom is refractory to conventional therapy including proton-pump inhibitor or vonoprazan and exhibit its FSSG score beyond 7.
Participants will be registered six years after the date of approval of this study.
Informed consent is obtained from all subjects before enrollment in the study.
Difficulty evaluating their own condition because of dementia or mental disturbance.
Heart or respiratory failure, spinal disease or other poor general condition.
Pregnant women or women who may be pregnant.
Those who are under the control of a randomized study regarding gastroesophageal reflux disease.
Those who are deemed inappropriate by their attending physician.
15
| 1st name | Tomoko |
| Middle name | |
| Last name | Nishimura |
Nishijin Hospital
Department of Internal Medicine
6028319
1035, Mizomaecho, Kamigyoku, kyoto, Japan.
0754618800
tnishimura@nishijinhp.com
| 1st name | Tomoko |
| Middle name | |
| Last name | Nishimura |
Nishijin Hospital
Department of Internal Medicine
6028319
1035, Mizomaecho, Kamigyoku, kyoto, Japan.
0754618800
tnishimura@nishijinhp.com
Nishijin Hpspital
Self-Funding
Self funding
Nishijin Hospital
1035, Mizomaecho, Kamigyoku, kyoto, Japan.
0754618800
tnishimura@nishijinhp.com
NO
| 2024 | Year | 10 | Month | 23 | Day |
Unpublished
Open public recruiting
| 2024 | Year | 10 | Month | 22 | Day |
| 2024 | Year | 10 | Month | 22 | Day |
| 2024 | Year | 10 | Month | 23 | Day |
| 2032 | Year | 10 | Month | 31 | Day |
| 2024 | Year | 10 | Month | 23 | Day |
| 2024 | Year | 10 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063901